The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression

BACKGROUND: Immune checkpoint inhibitor (ICI) therapy has improved patient survival in advanced cancers; however, the efficacy of ICIs in elderly patients is still elusive. This study assessed the efficacy of ICIs in elderly patients with advanced cancer in terms of overall survival (OS) and progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, C.M., Lee, J.B., Shin, S.J., Ahn, J.B., Lee, M., Kim, H.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588901/
https://www.ncbi.nlm.nih.gov/pubmed/36156450
http://dx.doi.org/10.1016/j.esmoop.2022.100577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588901/
https://www.ncbi.nlm.nih.gov/pubmed/36156450
http://dx.doi.org/10.1016/j.esmoop.2022.100577

Ejemplares similares